Repligen | RGEN - Dochód Netto





Dochód Netto Zmiana Data
Agilent USD 362M 23M 2026-06
Align Technology USD 108.29M 4.48M 2026-06
Bio Techne USD 51.05M 13.04M 2026-03
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Bruker USD -62.9M 66.4M 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Danaher USD 870M 159M 2026-06
Dentsply International USD 37M 47M 2026-06
General Electric Aerospace USD 2.37B 466M 2026-06
Henry Schein USD 94M 13M 2026-06
Illumina USD 207M 73M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Pfizer USD -248M 2.94B 2026-06
Repligen USD 5.01M 3.32M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Waters USD -136M 64M 2026-06
West Pharmaceutical Services USD 154M 15.2M 2026-06